ReviewCardiology research2025
Prevalence and Incidence of Dilated Cardiomyopathy in the United States and Western Europe: A Systematic Review.
Review in Cardiology research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Dilated cardiomyopathy (DCM) is a major contributing factor for heart failure and cardiac transplantation worldwide. Estimating the prevalence and incidence of DCM is critical for understanding the burden of illness in these patients and improving the landscape of preventative treatments. Previous reviews have shown substantial prevalence and incidence estimates for DCM within key regions such as the United States and several European countries. This review aimed to describe the published evidence on the prevalence and incidence of DCM within the United States, France, Germany, Italy, Spain, and the United Kingdom. Methods: MEDLINE Results: Of 6,145 identified articles, 10 unique studies were included in the review. Six studies reported prevalence, and five studies reported incidence of DCM in various populations. Prevalence estimates of DCM, including idiopathic and non-idiopathic causes, within adults (≥ 18 years) and/or heterogeneous (all ages) populations ranged from 42.8 to 118.3 per 100,000 persons; idiopathic DCM estimates ranged from 8.3 to 59.2 per 100,000 persons. Prevalence of adolescent (about 11 - 18 years) DCM, including idiopathic and non-idiopathic causes, ranged from 2.6 to 212.8 per 100,000 persons. Annual incidence rates of idiopathic DCM in adult/heterogeneous populations ranged from 6.0 to 7.0 per 100,000 persons. Annual incidence of DCM due to idiopathic/non-idiopathic causes among pediatric populations was reported as 0.6 per 100,000 persons. Reported prevalence and incidence rates by sex showed male preponderance, and estimates were higher in Black persons compared with White and Hispanic persons; higher DCM prevalence estimates were observed in studies utilizing newer DCM definitions using ICD coding compared with older definitions. Conclusion: This study highlights the varied prevalence and incidence rates of DCM reported across different geographic locations, time periods, sexes, races, and disease definitions. When comparing these rates, it is crucial to consider factors such as data sources, case definitions, case-finding methodologies, and study populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.